« Previous
Next »
Titles
- Considerations for design, development, and analytical validation of next generation sequencing (NGS)--based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff1
- Coverage of breast cancer screening and prevention services1
- Genetic testing for cystic fibrosis1
- Humanics and Genetic Engineering1
- Letter from Paul Berg and Maxine Singer to the editor of Nature1
- Medicare Part B spending on lab tests increased in 2021, driven by higher volume of COVID-19 tests, genetic tests, and chemistry tests1
- Pharmacogenomics: a primer for policymakers1
